Point72 (DIFC)’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-890
Closed -$4.83K 1848
2025
Q2
$4.83K Buy
890
+808
+985% +$4.03K ﹤0.01% 1385
2025
Q1
$285 Buy
+82
New +$398 ﹤0.01% 1605
2024
Q4
Sell
-763
Closed -$10.3K 1898
2024
Q3
$10.3K Buy
+763
New +$9.45K ﹤0.01% 1265

Other funds holding THRD

Point72 (DIFC)'s THRD Position: Q3 2025 in Review

Point72 (DIFC) sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 890 shares — an estimated $4.83K sold.

Point72 (DIFC) first reported a position in THRD in Q3 2024 and held it in 3 quarters. The position peaked at $10.3K in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Point72 (DIFC) reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 890 Third Harmonic Bio shares in Q3 2025, an estimated $4.83K.
  • Point72 (DIFC) first reported a position in Third Harmonic Bio in Q3 2024 and held it in 3 quarters.
  • Point72 (DIFC)'s Third Harmonic Bio position peaked at $10.3K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.